Thermo Fisher Scientific Inc. (TMO)
NYSE: TMO · Real-Time Price · USD
572.77
-2.47 (-0.43%)
At close: Dec 5, 2025, 4:00 PM EST
572.81
+0.04 (0.01%)
After-hours: Dec 5, 2025, 7:05 PM EST
Thermo Fisher Stock Forecast
Stock Price Forecast
The 17 analysts with 12-month price forecasts for Thermo Fisher stock have an average target of 615.47, with a low estimate of 535 and a high estimate of 670. The average target predicts an increase of 7.45% from the current stock price of 572.77.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Thermo Fisher stock from 18 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 3 | 4 | 4 | 5 |
| Buy | 9 | 10 | 11 | 11 | 11 | 11 |
| Hold | 4 | 4 | 3 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 17 | 17 | 17 | 17 | 18 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Maintains $656 → $670 | Buy | Maintains | $656 → $670 | +16.98% | Dec 2, 2025 |
| HSBC | HSBC | Hold → Strong Buy Upgrades $550 → $670 | Hold → Strong Buy | Upgrades | $550 → $670 | +16.98% | Dec 1, 2025 |
| Argus Research | Argus Research | Strong Buy Maintains $580 → $610 | Strong Buy | Maintains | $580 → $610 | +6.50% | Oct 29, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $560 → $656 | Buy | Maintains | $560 → $656 | +14.53% | Oct 28, 2025 |
| UBS | UBS | Hold Maintains $500 → $590 | Hold | Maintains | $500 → $590 | +3.01% | Oct 23, 2025 |
Financial Forecast
Revenue This Year
44.74B
from 42.88B
Increased by 4.33%
Revenue Next Year
46.95B
from 44.74B
Increased by 4.94%
EPS This Year
22.97
from 16.53
Increased by 38.96%
EPS Next Year
24.85
from 22.97
Increased by 8.19%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 46.7B | 49.3B | |||
| Avg | 44.7B | 46.9B | |||
| Low | 43.2B | 45.1B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 8.8% | 10.2% | |||
| Avg | 4.3% | 4.9% | |||
| Low | 0.7% | 0.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 23.95 | 26.25 | |||
| Avg | 22.97 | 24.85 | |||
| Low | 22.24 | 23.52 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 44.9% | 14.3% | |||
| Avg | 39.0% | 8.2% | |||
| Low | 34.5% | 2.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.